Opinion|Videos|October 29, 2024

Revolutionizing GPP Management: The Efficacy and Safety of Spesolimab in Preventing Life-Threatening Flares

Explore the groundbreaking findings from the Effisayil 2 trial on the efficacy and safety of subcutaneous spesolimab in preventing flares of generalized pustular psoriasis.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME